Workflow
BioCryst Pharmaceuticals(BCRX) - 2024 Q4 - Earnings Call Transcript

BioCryst Pharmaceuticals (BCRX) Q4 2024 Earnings Call February 24, 2025 08:30 AM ET Company Participants John Bluth - Chief Communications OfficerJon Stonehouse - CEO, President & Executive DirectorCharlie Gayer - CCOHelen Thackray - Chief R&D OfficerAnthony Doyle - Chief Financial OfficerBrian Abrahams - MD & Global Sector Head - Health Care ResearchGena Huidong Wang - Managing DirectorJon Wolleben - Managing DirectorSeema Sheoran - VP - Biotech Equity Research Conference Call Participants Tazeen Ahmad - A ...